Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Warp Drive Bio, Inc., a drug discovery company developing therapeutics
that exploit the molecules and mechanisms of nature, today announced
that Laurence Reid, Ph.D., president and chief executive officer of Warp
Drive Bio, will present at the Cowen and Company 38th Annual Health Care
Conference on Wednesday, March 14, 2018 at 12:00 p.m. ET at the Boston
Marriott Copley Place.

About Warp Drive Bio

Warp Drive Bio is exploiting the molecules and mechanisms of nature to
create transformative medicines. The company operates on the core
principle that nature is the world’s most powerful inventor of new
drugs, unconstrained by the mechanistic and synthetic limitations of
traditional medicinal chemistry. Warp Drive Bio is deploying its
proprietary Genome Mining™ and SMART™ (Small Molecule Assisted Receptor
Targeting) platforms to discover novel medicines that have the potential
to make a significant difference in patients’ lives. For more
information, please visit www.warpdrivebio.com.


Pure Communications, Inc.
Katie Engleman, 910-509-3977